Furthermore, we demonstrate a massive influx of activated CD8+ CTL in regressing mouse tumors as was also observed in two human neuroblastomas associated with Opsoclonus Myoclonus Syndrome (OMS). This evidence concerns the gene CD8A and neuroblastoma.